发布求助
文献互助 智能选刊 最新文献

A Case of ALK-rearranged Lung Cancer with a Durable Response to Atezolizumab Plus Bevacizumab/Carboplatin/Paclitaxel Combination Therapy After Initial Resistance to Alectinib

Q4 Medicine
Japanese Journal of Lung Cancer Pub Date : 2023-06-20 DOI:10.2482/haigan.63.195
Megumi Mizutani, Hwang Moon Hee, S. Uematsu, Y. Nishizaka
{"title":"A Case of ALK-rearranged Lung Cancer with a Durable Response to Atezolizumab Plus Bevacizumab/Carboplatin/Paclitaxel Combination Therapy After Initial Resistance to Alectinib","authors":"Megumi Mizutani, Hwang Moon Hee, S. Uematsu, Y. Nishizaka","doi":"10.2482/haigan.63.195","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":35081,"journal":{"name":"Japanese Journal of Lung Cancer","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Lung Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2482/haigan.63.195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
分享
查看原文 本刊更多论文
alk重排肺癌1例，在最初对阿勒替尼耐药后，对阿特唑单抗加贝伐单抗/卡铂/紫杉醇联合治疗有持久反应
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Japanese Journal of Lung Cancer
Japanese Journal of Lung Cancer Medicine-Oncology
CiteScore
0.10
自引率
0.00%
发文量
65
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信